These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study. Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW; J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-based three-drug combinations for the treatment of small cell lung cancer: a review of the Sarah Cannon Cancer Center experience. Hainsworth JD; Burris HA; Greco FA Semin Oncol; 2001 Apr; 28(2 Suppl 4):43-7. PubMed ID: 11479897 [TBL] [Abstract][Full Text] [Related]
4. Paclitaxel, carboplatin, and oral etoposide in the treatment of small cell lung cancer. Greco FA; Hainsworth JD Semin Oncol; 1996 Dec; 23(6 Suppl 16):7-10. PubMed ID: 9007113 [TBL] [Abstract][Full Text] [Related]
5. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature? Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975 [TBL] [Abstract][Full Text] [Related]
6. Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network. Hainsworth JD; Morrissey LH; Scullin DC; Houston GA; Prasthofer EF; Gray JR; Burris HA; Greco FA Cancer; 2002 May; 94(9):2426-33. PubMed ID: 12033195 [TBL] [Abstract][Full Text] [Related]
7. Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma. Kakolyris S; Agelidou A; Androulakis N; Tsaroucha E; Kouroussis Ch; Agelidou M; Karvounis N; Veslemes M; Christophylakis Ch; Argyraki A; Geroyianni A; Georgoulias V Lung Cancer; 2006 Jul; 53(1):59-65. PubMed ID: 16716447 [TBL] [Abstract][Full Text] [Related]
8. Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713. Edelman MJ; Chansky K; Gaspar LE; Leigh B; Weiss GR; Taylor SA; Crowley J; Livingston R; Gandara DR J Clin Oncol; 2004 Jan; 22(1):127-32. PubMed ID: 14701775 [TBL] [Abstract][Full Text] [Related]
9. Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions. Bunn PA Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-153-S12-162. PubMed ID: 9331142 [TBL] [Abstract][Full Text] [Related]
10. A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer. Birch R; Weaver CH; Hainsworth JD; Bobo C; Greco FA Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-135-S12-137. PubMed ID: 9331138 [TBL] [Abstract][Full Text] [Related]
11. A phase I study of topotecan/paclitaxel alternating with etoposide/cisplatin and thoracic irradiation in patients with limited small cell lung cancer. Lu C; Komaki R; Lee JS; Shin DM; Palmer JL; Coldman BJ; Pisters KM; Kurie JM; Fossella FV; Glisson BS Clin Cancer Res; 2003 Jun; 9(6):2085-91. PubMed ID: 12796372 [TBL] [Abstract][Full Text] [Related]
12. Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial. Reck M; von Pawel J; Macha HN; Kaukel E; Deppermann KM; Bonnet R; Ulm K; Hessler S; Gatzemeier U Lung Cancer; 2006 Jul; 53(1):67-75. PubMed ID: 16713013 [TBL] [Abstract][Full Text] [Related]
13. [Evidence based chemotherapy for lung cancer]. Watanabe H; Saijo N Gan To Kagaku Ryoho; 2000 Jan; 27(1):30-43. PubMed ID: 10660731 [TBL] [Abstract][Full Text] [Related]
14. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer. Bessho A; Ueoka H; Kiura K; Tabata M; Sunami K; Katayama Y; Yamane H; Hiraki A; Harada M Anticancer Res; 1999; 19(1B):693-8. PubMed ID: 10216478 [TBL] [Abstract][Full Text] [Related]
15. Oral etoposide and carboplatin. Effective therapy for elderly patients with small cell lung cancer. Evans WK; Radwi A; Tomiak E; Logan DM; Martins H; Stewart DJ; Goss G; Maroun JA; Dahrouge S Am J Clin Oncol; 1995 Apr; 18(2):149-55. PubMed ID: 7534977 [TBL] [Abstract][Full Text] [Related]
16. The current role and future prospects of paclitaxel in the treatment of small cell lung cancer. Hainsworth JD; Greco FA Semin Oncol; 1999 Feb; 26(1 Suppl 2):60-6. PubMed ID: 10190785 [TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy of small cell lung cancer]. Fukuoka M; Negoro S; Takada M; Kusunoki Y; Matsui K; Ryu S; Sakai N; Yamamoto H; Masuda N; Takifuji N Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):966-72. PubMed ID: 2839116 [TBL] [Abstract][Full Text] [Related]
18. Effective combination chemotherapy of carboplatin and paclitaxel in the treatment of a recurrent small-cell lung cancer patient. Kaira K; Ishizuka T; Yanagitani N; Sunaga N; Hisada T; Mori M Gan To Kagaku Ryoho; 2007 Feb; 34(2):225-7. PubMed ID: 17301532 [TBL] [Abstract][Full Text] [Related]
20. Etoposide plus ifosfamide plus cisplatin in the treatment of small cell lung cancer. Sandler AB Semin Oncol; 1998 Feb; 25(1 Suppl 2):38-41. PubMed ID: 9535210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]